Advances and Ongoing Challenges in Eosinophilic Gastrointestinal Disorders presented at the CEGIR/TIGERS Symposium at the 2024 American Academy of Allergy, Asthma, & Immunology Meeting
医学
哮喘
过敏
免疫学
作者
Benjamin L. Wright,J. Pablo Abonia,Edsel M. Abud,Seema S. Aceves,Steven J. Ackerman,Melinda Braskett,Joy W. Chang,Mirna Chehade,Gregory Constantine,Carla M. Davis,Evan S. Dellon,Alfred D. Doyle,Raquel Durban,David A. Hill,Elizabeth T. Jensen,Anupama Kewalramani,Paneez Khoury,Amy D. Klion,Leah C. Kottyan,Fei Li Kuang
The Consortium of Eosinophilic Gastrointestinal disease Researchers (CEGIR) and The International Gastrointestinal Eosinophil Researchers (TIGERS) organized a day-long symposium at the 2024 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. The symposium featured new discoveries in basic and translational research and debates on the mechanisms and management of eosinophilic gastrointestinal diseases (EGIDs). Updates on recent clinical trials and consensus guidelines were also presented. Herein, we summarize the updates on EGIDs presented at the symposium.